Inhibition of Dipeptidylpeptidase-IV by (2S)-Cyanopyrrolidine Inhibitors of Prolyl Endopeptidase

被引:0
|
作者
Makarov, G. I. [1 ]
Zolotov, N. N. [2 ]
Pozdnev, V. F. [3 ]
机构
[1] South Ural State Univ, Chelyabinsk 454080, Russia
[2] Zakusov Res Inst Pharmacol, Moscow 125315, Russia
[3] Inst Biomed Chem, Moscow 119121, Russia
关键词
prolyl endopeptidase; dipeptidyl peptidase; simulation; neuropeptides; aminoacyl-2-cyanopyrrolidine; molecular dynamics; EXPERIMENTAL-MODEL; 4; DPP4; DEPRESSION; OLIGOPEPTIDASE; PEPTIDASES; SERUM; RATS;
D O I
10.1134/S1068162024060281
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective: Prolyl endopeptidase (PEP) and dipeptidyl peptidase IV (DPP4) are serine peptidases, cleaving peptides at the carboxyl group of proline residues. These enzymes are involved in the regulation of many physiological processes, participating in the production, modification, and utilization of neuropeptides and peptide hormones. We found that compounds of the X-Y-2-S-cyanopyrrolidine general formula, where X is a protecting group and Y is any amino acid other than glycine and proline, which are PEP inhibitors, also inhibit DPP4. To explain the unexpected ability of these compounds to inhibit DPP4, we set out to develop a structurally reasoned insights of their interaction with the PEP and DPP4 active sites. Methods: To achieve this goal, we synthesized a series of N-protected amino acid derivatives of 2-S-cyanopyrrolidine, determined their inhibition constants for PEP and DPP4, and performed molecular dynamics modeling of the structures of these complexes. Results and Discussion: X-Y-2-S-pyrrolidine PEP inhibitors can inhibit DPP4, if X is a benzyloxycarbonyl or succinyl protecting group and Y is not a glycine or proline residue, i.e., they are L-amino acid residues with side chains. Among them, N-benzyloxycarbonylamino-L-methionyl-2S-pyrrolidine-2-carbonitrile has pronounced antiamnesic activity. Molecular dynamics modeling showed that the large hydrophobic side chain of methionine or tryptophan residues in the inhibitor ensures its binding to the active site of DPP4, compensating for steric hindrance created by the N-protecting group. Conclusions: Using molecular dynamics modeling methods, we established a relationship between the structure of 2-S-cyanopyrrolidine amino acid derivatives and their ability to inhibit DPP4. This opens the prospect of creating new drugs, affecting the peptidergic link in the regulation of functional systems in normal conditions and in various pathological processes.
引用
收藏
页码:2366 / 2378
页数:13
相关论文
共 50 条
  • [41] Dimethylbis(4-methylpiperidine-1-dithio-carboxylato-κ2S,S′)tin(IV)
    Shahzadi, S
    Ali, S
    Fettouhi, M
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : M1178 - M1180
  • [42] (N,N-Diallyldithiocarbamato-κ2S,S′)triphenyl-tin(IV) and bis(N,N-di-κ2S,S′)-diphenyltin(IV): crystal structure, Hirshfeld surface analysis and computational study
    Haezam, Farah Natasha
    Awang, Normah
    Kamaludin, Nurul Farahana
    Jotani, Mukesh M.
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2020, 76 : 167 - +
  • [43] Lead optimization of [(S)-γ-(arylamino)prolyl]thiazolidine focused on γ-substituent:: Indoline compounds as potent DPP-IV inhibitors
    Sakashita, Hiroshi
    Akahoshi, Fumihiko
    Yoshida, Tomohiro
    Kitajima, Hiroshi
    Hayashi, Yoshiharu
    Ishii, Shinichi
    Takashina, Yoko
    Tsutsumiuchi, Reiko
    Ono, Satoshi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (02) : 641 - 655
  • [44] Bis(tetraphenylphosphonium) tris[N-(methylsulfonyl)dithiocarbimato(2-)-κ2S,S′]stannate(IV)
    Barolli, Joao P.
    Oliveira, Marcelo R. L.
    Correa, Rodrigo S.
    Ellena, Javier
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : M1154 - +
  • [45] Synthesis and structure-activity relationships of potent 1-(2-substituted-aminoacetyl)-4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors
    Fukushima, Hiroshi
    Hiratate, Akira
    Takahashi, Masato
    Saito-Hori, Masako
    Munetomo, Eiji
    Kitano, Kiyokazu
    Saito, Hidetaka
    Takaoka, Yuji
    Yamamoto, Koji
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, 56 (08) : 1110 - 1117
  • [46] Inhibition of breast cancer growth and invasion by single-minded 2s
    Kwak, Hyeong-Il
    Gustafson, Tanya
    Metz, Richard P.
    Laffin, Brian
    Schedin, Pepper
    Porter, Weston W.
    CARCINOGENESIS, 2007, 28 (02) : 259 - 266
  • [47] Di-tert-butylbis(N-isopropyl-N-methyldithiocarbamato-κ2S,S′)tin(IV)
    Muthalib, Amirah Faizah
    Baba, Ibrahim
    Samsudin, Mohd Wahid
    Ng, Seik Weng
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : M356 - U223
  • [48] Di-tert-butylchloro(N,N-dimethyldithio-carbamato-κ2S,S′)tin(IV)
    Li, F
    Yin, HD
    Zhai, J
    Wang, DQ
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : M300 - M301
  • [49] Effects of glycosylation of (2S,4R)-4-hydroxyproline on the conformation, kinetics, and thermodynamics of prolyl amide isomerization
    Owens, Neil W.
    Braun, Craig
    O'Neil, Joe D.
    Marat, Kirk
    Schweizer, Frank
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (38) : 11670 - +
  • [50] Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by vildagliptin ((2S)-{[3-hydroxyadamantan-1-yl) amino]acetyl}-pyrrolidine-2-carbonitrile)
    Brandt, I
    Joossens, J
    Chen, X
    Maes, MB
    Scharpé, S
    De Meester, I
    Lambeir, AM
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (01) : 134 - 143